CoChat

Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands

Open access
Molenaar, Nina Maren, Lambregtse-van den Berg, Mijke Pietertje, Bonsel, Gouke Jacobus · 2020 · Archives of Women's Mental Health

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

Management of mental illness in the perinatal period with antidepressants is controversial, since evidence emerged on potential harmful effects to the unborn child. However, over time, the dispensing of antidepressants in the perinatal period has increased. We examined perinatal dispensing patterns over time and the role of a recently issued guideline in this regard. We identified a 16-year cohort of 153,952 Dutch pregnancies with a delivery date between January 1999 and December 2014. Data included exposure to selective serotonin reuptake inhibitors (SSRIs) related to phases of pregnancy (preconception, pregnancy and delivery, post-delivery). The chi-square test for trends was used. With standard logistic regression, we explored the influence of patient characteristics on continuation of SSRIs during pregnancy. A persistent significant rise of dispensing rates in all phases was observed, with the largest increase during pregnancy (from 0.8% in 1999/2000 to 2.1% in 2013/2014, chi-square for trend = 141.735, p < 0.001). A substantial change of practice in terms of the SSRI used (less paroxetine) and the policy towards continuation into pregnancy (more continuation over time) was visible. Concomitant use of psycholeptics halved the probability of continuation of SSRIs (OR 0.50, 95%CI 0.43-0.55, p < 0.01). Dispensing rates of SSRIs steadily increased last 16 years, especially during pregnancy, caused by an increase in the proportion of women continuing their medication during pregnancy. In view of the demonstrated impact of uncertainty regarding effectiveness and safety of SSRIs in pregnancy, future research should involve more detailed outcome research of SSRIs as it is, and research into viable alternatives.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00737-019-0951-5

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Selective serotonin reuptake inhibitors (SSRIs) perinatal dispensing rate per time period of interest per 100 pregnancies in the Netherlands, 1999–2014. 1 = the year before pregnancy, 2 = during pregnancy, 3 = the year after pregnancy. Complete data on all three phases was available for all women and thus the number of women at risk for each bar (1, 2 and 3) per 2 years is comparable. For example, a woman with a delivery date in 1999, who took SSRIs during all three phases (before, during, after) is represented in blue in all three bars (1, 2, 3) of the 1999 column. The dark blue bars represent the women that used their SSRI since the year before pregnancy. The pink and green bars represent the women that did not use SSRIs in the year before pregnancy but started using them during or after pregnancy respectively. The light blue bar represents those women that used SSRIs before pregnancy, discontinued during pregnancy, but restarted in the year after pregnancy
Fig. 1 Selective serotonin reuptake inhibitors (SSRIs) perinatal dispensing rate per time period of interest per 100 pregnancies in the Netherlands, 1999–2014. 1 = the year before pregnancy, 2 = during pregnancy, 3 = the year after pregnancy. Complete data on all three phases was available for all women and thus the number of women at risk for each bar (1, 2 and 3) per 2 years is comparable. For example, a woman with a delivery date in 1999, who took SSRIs during all three phases (before, during, after) is represented in blue in all three bars (1, 2, 3) of the 1999 column. The dark blue bars represent the women that used their SSRI since the year before pregnancy. The pink and green bars represent the women that did not use SSRIs in the year before pregnancy but started using them during or after pregnancy respectively. The light blue bar represents those women that used SSRIs before pregnancy, discontinued during pregnancy, but restarted in the year after pregnancyCC BY · PubMed Central
Fig. 2 Percentage of women with selective serotonin reuptake inhibitor (SSRI) dispensing in the year before pregnancy continuing during pregnancy in the Netherlands, 1999–2014. Dotted lines represent the 95% confidence intervals
Fig. 2 Percentage of women with selective serotonin reuptake inhibitor (SSRI) dispensing in the year before pregnancy continuing during pregnancy in the Netherlands, 1999–2014. Dotted lines represent the 95% confidence intervalsCC BY · PubMed Central
Fig. 3 Relative and absolute dispensing rates per specific selective serotonin reuptake inhibitor (SSRI) before, during and after pregnancy in the Netherlands, 1999–2015. a Relative SSRI dispensing in the year before pregnancy. b Absolute SSRI dispensing in the year before pregnancy. c Relative SSRI dispensing during pregnancy. d Absolute SSRI dispensing during pregnancy. e Relative SSRI dispensing in the year after pregnancy. f Absolute SSRI dispensing in the year after pregnancy. Each year represents two calendar years
Fig. 3 Relative and absolute dispensing rates per specific selective serotonin reuptake inhibitor (SSRI) before, during and after pregnancy in the Netherlands, 1999–2015. a Relative SSRI dispensing in the year before pregnancy. b Absolute SSRI dispensing in the year before pregnancy. c Relative SSRI dispensing during pregnancy. d Absolute SSRI dispensing during pregnancy. e Relative SSRI dispensing in the year after pregnancy. f Absolute SSRI dispensing in the year after pregnancy. Each year represents two calendar yearsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 2

  1. Bijlsma MJ, Oortgiesen BE Beernink RHJ, Bos J, Wilffert B, Hak E (2014) The effect of the warning by the Dutch Medicines Evaluation Board on the trend in SSRI utilization in the Netherlands from 1998 to 2010. Pharm Weekbl 149(8):32–36
  2. NVOG (2012) Richtlijn: SSRI-gebruik in de zwangerschap en tijdens de lactatie. Nederlandse Vereniging voor Obstetrie en Gynaecologie, Utrecht

Cited by

See all 30

Metadata

Authors
Molenaar, N. M., Lambregtse-van den Berg, M. P., & Bonsel, G. J.
Affiliations
  • Mount Sinai Hospital (US)
  • Erasmus MC (NL)
Corresponding author
Molenaar, Nina Maren
Venue
Archives of Women's Mental Health
Published
2019-02-14
Volume
23
Issue
1
Pages
71-79
ISSN
  • 1434-1816 (ISSN-L)
  • 1435-1102
OpenAlex
W2911710526
Cited by
30
References
39
Citations by year
2025: 5 · 2024: 5 · 2023: 1 · 2022: 7 · 2021: 2 · 2020: 7 · 2019: 3
FWCI
4.37
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • Archives of Women s Mental Health (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
Funders
Erasmus Medisch Centrum (n/a)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
selective serotonin reuptake inhibitors, antidepressant use in pregnancy, perinatal mental disorders, paroxetine, psycholeptics, guideline changes, maternal mental health, prescribing trends
MeSH terms
Adult, Antidepressive Agents, Female, Humans, Netherlands, Population, Pregnancy, Pregnancy Complications, Drug Prescriptions, Cohort Studies, Selective Serotonin Reuptake Inhibitors, Paroxetine, Postpartum Period, Peripartum Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands. https://app.cochat.ai/papers/10.1007/s00737-019-0951-5
The paper
Molenaar, N. M., Lambregtse-van den Berg, M. P., & Bonsel, G. J. (2020). Dispensing patterns of selective serotonin reuptake inhibitors before, during and after pregnancy: a 16-year population-based cohort study from the Netherlands. Archives of Women's Mental Health. https://doi.org/10.1007/s00737-019-0951-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.